Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal of the American Heart Association
|
November 8, 2021
Trends and Outcomes of Cardiac Transplantation in the Lowest Urgency Candidates
Michael A Fuery, Fouad Chouairi, Peter Natov, et al.
Science Signaling
|
March 21, 2023
Hedgehog-induced ZFYVE21 promotes chronic vascular inflammation by activating NLRP3 inflammasomes in T cells
Bo Jiang, Shaoxun Wang, Guiyu Song, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 2008
The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase
Andrew K Takle, Mark J Bamford, Susannah Davies, et al.
Biochemical Pharmacology
|
February 6, 2007
Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats
Andrew D Medhurst, Michael A Briggs, Gordon Bruton, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 29, 2013
The discovery of the benzazepine class of histamine H3 receptor antagonists
David M Wilson, James Apps, Nicholas Bailey, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2013
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists
David M Wilson, James Apps, Nicholas Bailey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 2007
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models
Andrew D Medhurst, Alan R Atkins, Isabel J Beresford, et al.
Journal of Medicinal Chemistry
|
January 7, 2020
Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening
Christopher R Wellaway, Dominique Amans, Paul Bamborough, et al.
Journal of Medicinal Chemistry
|
June 12, 2024
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787
David J Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal of the American Heart Association
|
November 8, 2021
Trends and Outcomes of Cardiac Transplantation in the Lowest Urgency Candidates
Michael A Fuery, Fouad Chouairi, Peter Natov, et al.
Science Signaling
|
March 21, 2023
Hedgehog-induced ZFYVE21 promotes chronic vascular inflammation by activating NLRP3 inflammasomes in T cells
Bo Jiang, Shaoxun Wang, Guiyu Song, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 2008
The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase
Andrew K Takle, Mark J Bamford, Susannah Davies, et al.
Biochemical Pharmacology
|
February 6, 2007
Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats
Andrew D Medhurst, Michael A Briggs, Gordon Bruton, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 29, 2013
The discovery of the benzazepine class of histamine H3 receptor antagonists
David M Wilson, James Apps, Nicholas Bailey, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2013
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists
David M Wilson, James Apps, Nicholas Bailey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 2007
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models
Andrew D Medhurst, Alan R Atkins, Isabel J Beresford, et al.
Journal of Medicinal Chemistry
|
January 7, 2020
Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening
Christopher R Wellaway, Dominique Amans, Paul Bamborough, et al.
Journal of Medicinal Chemistry
|
June 12, 2024
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787
David J Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Page
of 3